Theravance Biopharma Stock Math Transform Price Ceiling Movement

TBPH Stock  USD 9.47  0.14  1.46%   
Theravance Biopharma math transform tool provides the execution environment for running the Price Ceiling Movement transformation and other technical functions against Theravance Biopharma. Theravance Biopharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of math transform indicators. As with most other technical indicators, the Price Ceiling Movement transformation function is designed to identify and follow existing trends. Analysts that use price transformation techniques rely on the belief that biggest profits from investing in Theravance Biopharma can be made when Theravance Biopharma shifts in price trends from positive to negative or vice versa.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Theravance Biopharma Price Ceiling Movement function is a real number to the largest previous price integer.

Theravance Biopharma Technical Analysis Modules

Most technical analysis of Theravance Biopharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Theravance from various momentum indicators to cycle indicators. When you analyze Theravance charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Theravance Biopharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Theravance Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Theravance Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing Theravance Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Theravance Biopharma's daily price indicators and compare them against related drivers, such as math transform and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Theravance Biopharma's intrinsic value. In addition to deriving basic predictive indicators for Theravance Biopharma, we also check how macroeconomic factors affect Theravance Biopharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 (projected)
Payables Turnover2.354.2426.65
Days Of Inventory On Hand513.2383.819.0E-6
Hype
Prediction
LowEstimatedHigh
7.419.4711.53
Details
Intrinsic
Valuation
LowRealHigh
5.687.749.80
Details
Naive
Forecast
LowNextHigh
7.869.9211.98
Details
5 Analysts
Consensus
LowTargetHigh
12.1913.4014.87
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run CEOs Directory Now

   

CEOs Directory

Screen CEOs from public companies around the world
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Casinos Idea
Casinos
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 60 shares
Impulse Idea
Impulse
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 40 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Chemicals Idea
Chemicals
Invested over 30 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
ESG Investing Idea
ESG Investing
Invested few shares
When determining whether Theravance Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Theravance Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Theravance Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Theravance Biopharma Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theravance Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in Theravance Stock please use our How to Invest in Theravance Biopharma guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Theravance Biopharma. If investors know Theravance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Theravance Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.03)
Revenue Per Share
1.293
Quarterly Revenue Growth
0.075
Return On Assets
(0.06)
Return On Equity
(0.23)
The market value of Theravance Biopharma is measured differently than its book value, which is the value of Theravance that is recorded on the company's balance sheet. Investors also form their own opinion of Theravance Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Theravance Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Theravance Biopharma's market value can be influenced by many factors that don't directly affect Theravance Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Theravance Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Theravance Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theravance Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.